Drugs & Targets Sheba Medical Center, Roche collaborate to transform NSCLC diagnostics with AI-powered digital pathology November 22, 2024Vol.50 No.44
Drugs & Targets Immunai to collaborate with Teva to enhance clinical decision making in immuno-oncology clinical trials November 22, 2024Vol.50 No.44
Regulatory News Ready or not, AI-based decision support tools are entering oncology clinicsRegulators and health systems must adapt November 15, 2024Vol.50 No.43By McKenzie Prillaman
White House As Trump’s HHS pick, RFK Jr. stands to honor or squander the Kennedy legacy in cancer November 15, 2024Vol.50 No.43By Paul Goldberg
Kaklamani: The San Antonio Breast Cancer Symposium will focus on deescalating treatment while maintaining outcomes November 15, 2024Vol.50 No.43By Jacquelyn Cobb
A clinic at Fred Hutch addresses sexual health needs of patients with breast cancerData indicate low adherence to ASCO guideline November 15, 2024Vol.50 No.43By Claire Marie Porter
Trials & Tribulations How we improved the treatment of Hodgkin lymphoma November 15, 2024Vol.50 No.43By Alex Herrera
In Brief MD Anderson launches Institute for Cell Therapy Discovery & Innovation November 15, 2024Vol.50 No.43
In Brief NCI renews IU Simon Comprehensive Cancer Center’s designation November 15, 2024Vol.50 No.43
